Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Idarubicin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,070,608Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Teva's troubled plant seen to create injectable drug shortages
    Teva's troubled plant seen to create injectable drug shortages

    24 May 2022

    // Joseph Keenan FIERCEPHARMA

    https://www.fiercepharma.com/manufacturing/tevas-halt-production-troubled-plant-seen-create-shortages-range-injectables

    Joseph Keenan FIERCEPHARMA
    24 May 2022
    Share Share
    Enforcement Report - Week of April 20, 2022
    Enforcement Report - Week of April 20, 2022

    20 Apr 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-20-2022-1650431289.pdf

    FDA
    20 Apr 2022
    Share Share
    Particulates have prompted yet another injectable drug recall
    Particulates have prompted yet another injectable drug recall

    31 Mar 2022

    // F. Kansteiner FIERCEPHARMA

    https://www.fiercepharma.com/pharma/teva-recalls-one-lot-leukemia-med-after-discovering-injectable-drugs-nemesis-particulates

    F. Kansteiner FIERCEPHARMA
    31 Mar 2022
    Share Share
    Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Inj
    Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Inj

    30 Mar 2022

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-issues-voluntary-nationwide-recall-one-lot-idarubicin-hydrochloride-injection-usp-5-mg5-ml-due

    FDA
    30 Mar 2022
    Share Share
    Drug combination an alternative leukaemia treatment to chemotherapy
    Drug combination an alternative leukaemia treatment to chemotherapy

    12 Nov 2021

    // Anna Begley EUROPEANPHARMACEUTICALREVIEW

    https://www.europeanpharmaceuticalreview.com/news/165376/drug-combination-an-alternative-leukaemia-treatment-to-chemotherapy/

    Anna Begley EUROPEANPHARMACEUTICALREVIEW
    12 Nov 2021
    Share Share
    Enforcement Report - Week of August 25, 2021
    Enforcement Report - Week of August 25, 2021

    25 Aug 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf

    FDA
    25 Aug 2021
    Share Share